European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - pigs - for active immunisation of pigs from 7 weeks of age onwards to prevent mortality and reduce infection and disease caused by classical swine fever virus (csfv).onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv.onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - classical swine fever e2 recombinant bvdv - lyophilisate and solvent for solution for injection - live viral vaccine - pigs

European Union - English - EMA (European Medicines Agency)

intervet international bv - classical swine fever virus (csfv) -e2 subunit antigen - immunologicals for suidae - pigs - active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of classical swine fever, as well as to reduce infection with and excretion of csf field virus.the onset of protection is 2 weeks.the duration of protection is 6 months.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - classical swine fever virus (live, modified) - lyophilisate and solvent for solution for injection - classical swine fever virus (csfv) - classical swine fever virus - pig